TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.

Robin Kate Kelley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.